Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients

OBJECTIVES: Hepatic hydrothorax (HH) is a predictor of poor survival in cirrhosis patients. However, whether HH increases the mortality risk of cirrhosis patients treated with transjugular intrahepatic portosystemic shunt (TIPS) is unknown. Our objective was to evaluate the influence of HH on the su...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Xiaoyuan, Jia, Wenyuan, He, Chuangye, Yuan, Xulong, Niu, Jing, Xu, Jiao, Han, Na, Zhu, Ying, Wang, Wenlan, Tie, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Vascular-Interventional
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121519/
https://www.ncbi.nlm.nih.gov/pubmed/36576548
http://dx.doi.org/10.1007/s00330-022-09357-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121519/
https://www.ncbi.nlm.nih.gov/pubmed/36576548
http://dx.doi.org/10.1007/s00330-022-09357-3

Ejemplares similares